Literature DB >> 11123723

Paraneoplastic cerebellar ataxia with mild cerebello-olivary degeneration and an anti-neuronal antibody: a clinicopathological study.

M Yaginuma, K Ishida, T Uchihara, F Suzuki, M Aoki, T Tanaka, H Murase, K Ikeda, H Mizusawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11123723     DOI： 10.1046/j.0305-1846.2000.00285.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN： 0305-1846            Impact factor:   8.090


× No keyword cloud information.
  5 in total

Review 1.  The emerging neuropathology of essential tremor.

Authors:  Elan D Louis; Jean Paul G Vonsattel
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

2.  Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  Roxanne Larivière; Rébecca Gaudet; Benoit J Gentil; Martine Girard; Talita Cristiane Conte; Sandra Minotti; Kim Leclerc-Desaulniers; Kalle Gehring; R Anne McKinney; Eric A Shoubridge; Peter S McPherson; Heather D Durham; Bernard Brais
Journal:  Hum Mol Genet       Date:  2014-09-26       Impact factor: 6.150

3.  Purkinje cell axonal torpedoes are unrelated to advanced aging and likely reflect cerebellar injury.

Authors:  Elan D Louis; Phyllis L Faust; Jean-Paul G Vonsattel; Cordelia Erickson-Davis
Journal:  Acta Neuropathol       Date:  2009-04-10       Impact factor: 17.088

4.  Torpedoes in Parkinson's disease, Alzheimer's disease, essential tremor, and control brains.

Authors:  Elan D Louis; Phyllis L Faust; Jean-Paul G Vonsattel; Lawrence S Honig; Alex Rajput; Ali Rajput; Rajesh Pahwa; Kelly E Lyons; Webster G Ross; Rodger J Elble; Cordelia Erickson-Davis; Carol B Moskowitz; Arlene Lawton
Journal:  Mov Disord       Date:  2009-08-15       Impact factor: 10.338

Review 5.  Essential tremor pathology: neurodegeneration and reorganization of neuronal connections.

Authors:  Elan D Louis; Phyllis L Faust
Journal:  Nat Rev Neurol       Date:  2020-01-20       Impact factor: 42.937
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.